» Authors » Sandra Nuyts

Sandra Nuyts

Explore the profile of Sandra Nuyts including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 167
Citations 2456
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peirelinck H, De Gendt C, Lenssen O, Nuyts S, Van Eycken L
Eur J Cancer . 2025 Feb; 218:115300. PMID: 39965995
No abstract available.
2.
Vergauwen A, Baudelet M, Van den Steen L, Goeleven A, Nuyts S, Nevens D, et al.
Head Neck . 2025 Jan; PMID: 39854098
Background: Radiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation-associated dysphagia (RAD). These...
3.
Van Aperen K, De Groef A, Troosters T, Elshout P, Nuyts S
Support Care Cancer . 2025 Jan; 33(2):107. PMID: 39820655
Purpose: This study evaluates the feasibility of a comprehensive supervised exercise program (CSEP) for head and neck cancer (HNC) patients during and after (chemo)radiotherapy, integrating quantitative and qualitative data to...
4.
Bollen H, Dok R, De Keyzer F, Deschuymer S, Laenen A, Devos J, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766182
Background: This study aimed to explore the differences in quantitative diffusion-weighted (DW) MRI parameters in oropharyngeal squamous cell carcinoma (OPC) based on Human Papillomavirus (HPV) status before and during radiotherapy...
5.
Strojan P, Kokalj M, Plavc G, Ng S, Nuyts S, Chiesa-Estomba C, et al.
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893215
Stereotactic body radiotherapy (SBRT) is characterized by a high dose per fraction, well-defined small targets, superior dose conformity, and a steep off-target dose gradient. A literature search was conducted to...
6.
Dok R, Vanderwaeren L, Verstrepen K, Nuyts S
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893080
Photon-based radiotherapy (XRT) is one of the most frequently used treatment modalities for HPV-negative and HPV-positive locally advanced head and neck squamous cell carcinoma (HNSCC). However, locoregional recurrences and normal...
7.
Tham J, Ng S, Khor R, Wada M, Gan H, Thai A, et al.
J Clin Med . 2024 Jun; 13(11). PMID: 38892731
The treatment of head and neck cancers (HNCs) encompasses a complex paradigm involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional recurrence is a common cause of treatment failure,...
8.
Remmerie M, Dok R, Wang Z, Omella J, Alen S, Cokelaere C, et al.
Cell Oncol (Dordr) . 2024 Jun; 47(5):1811-1829. PMID: 38888850
Purpose: Uterine serous carcinoma (USC) is generally associated with poor prognosis due to a high recurrence rate and frequent treatment resistance; hence, there is a need for improved therapeutic strategies....
9.
Nuyts S, Bollen H, Eisbruch A, Strojan P, Mendenhall W, Ng S, et al.
Cancer Med . 2024 Apr; 13(8):e7192. PMID: 38650546
Background: Patients with head and neck cancer (HNC) may experience substantial anatomical changes during the course of radiotherapy treatment. The implementation of adaptive radiotherapy (ART) proves effective in managing the...
10.
Dong J, Ng W, Wong C, Li J, Bollen H, Chow J, et al.
Radiother Oncol . 2024 Mar; 195():110258. PMID: 38537680
This systematic review examines the role of dosimetric parameters in predicting temporal lobe necrosis (TLN) risk in nasopharyngeal carcinoma (NPC) patients treated with three-dimensional conformal RT (3D-CRT), intensity-modulated radiation therapy...